Top

Clinical Research in Cardiology

Published in:

01-06-2013 | Letter to the Editors

Atrial standstill in a patient with progressive severe heart failure

Authors: Marco R. Schroeter, Gerd Hasenfuß, Markus Zabel, Dirk Vollmann

Published in: Clinical Research in Cardiology | Issue 6/2013

Excerpt

Sirs: …

Nakazato Y, Nakata Y, Hisaoka T, Sumiyoshi M, Ogura S, Yamaguchi H (1995) Clinical and electrophysiological characteristics of atrial standstill. Pacing Clin Electrophysiol 18:1244–1254PubMedCrossRef

Fazelifar AF, Arya A, Haghjoo M, Sadr-Ameli MA (1995) Familial atrial standstill in association with dilated cardiomyopathy. Pacing Clin Electrophysiol 28:1005–1008CrossRef

Mangrum JM, DiMarco JP (2000) The evaluation and management of bradycardia. N Engl J Med 342:703–709PubMedCrossRef

Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen IM, Sandkuijl L, Smits JP, Hulsbeek M, Rook MB, Jongsma HJ, Wilde AA (2003) A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92:14–22PubMedCrossRef

Talwar KK, Radhakrishnan S, Chopra P (1988) Myocarditis manifesting as persistent atrial standstill. Int J Cardiol 20:283–286PubMedCrossRef

Koshimizu TA, Komori S, Ishihara T, Kohno I, Umetani K, Sawanobori T, Ijiri H, Tamura K (2002) Restored atrial excitability after late recanalization in a patient with atrial standstill and acute myocardial infarction. Pacing Clin Electrophysiol 25:217–219PubMedCrossRef

Park SR, Kwak CH, Kang YR, Seo MK, Kang MK, Cho JH, Ahn YJ, Hwang JY (2009) Implantable cardioverter-defibrillator implantation in a patient with atrial standstill. Yonsei Med J 50:156–159PubMedCrossRef

El Menyar AA, Gendi SM (2006) Persistent atrial standstill in noncompaction cardiomyopathy. Pediatr Cardiol 27:364–366PubMedCrossRef

Wolf-Puetz A, Wein M, Niehues R, Horlitz M, Kelm M, Klingel K, Kandolf R, Klein RM (2011) Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy. Clin Res Cardiol 100:253–260PubMedCrossRef

10.

Azaouagh A, Churzidse S, Konorza T, Erbel R (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res Cardiol 100:383–394PubMedCrossRef

11.

Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263–272PubMedCrossRef

12.

Böhm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100:973–981PubMedCrossRef

13.

Suguta M, Hara K, Nakano A, Amano A, Hasegawa A, Kurabayashi M (2000) Serum atrial natriuretic peptide concentration is a useful predictor of atrial standstill in patients with heart failure. Jpn Circ J 64:537–540PubMedCrossRef

14.

Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, Dimopoulos NP, Filippatos GS, Sideris A, Kardaras F (2009) Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol 98:208–212PubMedCrossRef

Title: Atrial standstill in a patient with progressive severe heart failure
Authors: Marco R. Schroeter
Gerd Hasenfuß
Markus Zabel
Dirk Vollmann
Publication date: 01-06-2013
Publisher: Springer-Verlag
Published in: Clinical Research in Cardiology / Issue 6/2013
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-013-0557-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Atrial standstill in a patient with progressive severe heart failure

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2013

Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany

First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model

Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban

Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany

Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry